Lifevantage Corporation LFVN Interest Income (Expense), Nonoperating

Interest Income (Expense), Nonoperating at other companies

NAG

Niagen Bioscience, Inc. Common StockNAGE

——

Solesence, Inc. Common StockSLSN

——

Biote Corp.BTMD

——

KenvueKVUE

——

Other financials

Income statement

See full

Revenue$43.7M-25.2%

Gross profit$34.5M-27.0%

Operating income$1.7M-58.6%

Net income$1.4M-60.7%

EPS (diluted)$0.11-57.7%

Balance sheet

See full

Cash & equivalents$12.5M-44.4%

Total debt$10.2M-17.4%

Total equity$33.3M-2.0%

Total assets$62.1M-19.6%

Cash flow

See full

Operating cash flow$5.0M+124%

CapEx$1.0M+205%

Free cash flow$4.0M+110%

Valuation

See full

Market cap$78.72M-51.4%

Enterprise value$76.45M-50.2%

P/E13.7×-2.8×

P/S0.4×-0.3×

Profitability

See full

Gross margin78.1%-2.2pp

Operating margin3.4%-2.5pp

Net margin2.9%-1.2pp

FCF margin3.8%+1.1pp

Returns & leverage

See full

Return on equity17.1%-13.0pp

Debt / equity0.3×-0.1×

Current ratio2×+0.3×

Where this comes from

Reported directly by Lifevantage Corporation in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: Lifevantage Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifevantage Corporation's interest income (expense), nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lifevantage Corporation's interest income (expense), nonoperating?: Lifevantage Corporation (LFVN) reported interest income (expense), nonoperating of $24K in Q1 2026.
How has Lifevantage Corporation's interest income (expense), nonoperating changed year-over-year?: Lifevantage Corporation's interest income (expense), nonoperating decreased by 81.7% year-over-year, from $131K to $24K.